+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Superdisintegrants Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Superdisintegrants Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Sale

Superdisintegrants Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 199 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 5336394
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Superdisintegrants Market grew from USD 629.44 million in 2024 to USD 699.67 million in 2025. It is expected to continue growing at a CAGR of 10.96%, reaching USD 1.17 billion by 2030.

Superdisintegrants serve as essential excipients designed to facilitate the rapid breakup of orally administered dosage forms once they reach the gastrointestinal tract. By promoting immediate release profiles, these agents optimize therapeutic efficacy, accelerate onset of action and enhance patient compliance. Their functionality is critical for a broad spectrum of dosage formats, supporting pressing needs in areas such as pain management, cardiovascular therapy and neurological treatments. Recent advancements in material science and formulation engineering have elevated performance standards, offering novel delivery mechanisms that respond dynamically to physiological triggers. As drug pipelines continue to prioritize fast-acting and patient-centric designs, the demand for high-performance superdisintegrants intensifies. Moreover, the drive toward sustainable and naturally derived ingredients has spurred innovations in alginates, gums and starch-based variants, while synthetic counterparts such as crospovidone, crosscarmellose sodium and sodium starch glycolate continue to evolve through proprietary modifications. This introduction sets the stage for an in-depth exploration of market dynamics, regulatory shifts and strategic imperatives required to navigate a rapidly changing environment, ensuring that decision-makers remain equipped with the insights needed to capitalize on emerging opportunities.

Transformative Shifts Shaping the Superdisintegrants Sector

Over the past decade, the superdisintegrants landscape has undergone transformative shifts driven by increasing regulatory scrutiny, evolving patient expectations and breakthroughs in excipient engineering. The emergence of patient-friendly formats has prompted formulators to harness advanced materials that deliver rapid dispersion without compromising stability. Concurrently, sustainability mandates have accelerated the adoption of naturally derived agents, stimulating research into biopolymer extraction techniques and green processing methods. On the synthetic front, the refinement of crosslinked polyvinylpyrrolidone and carmellose derivatives has enhanced water uptake kinetics, thus improving disintegration profiles even at lower concentrations. Technological convergence with 3D printing and continuous manufacturing platforms is further redefining production paradigms, allowing for personalized dosage and on-demand manufacturing. Regulatory changes emphasizing excipient quality and traceability are catalyzing investments in supply chain transparency, with real-time analytics and blockchain-based provenance tracking gaining traction. As global health challenges intensify the need for rapid drug deployment, stakeholders across the value chain must adapt to these shifts, balancing speed-to-market imperatives with rigorous quality assurance to maintain competitive advantage.

Cumulative Impact of US Tariffs on Superdisintegrants in 2025

The introduction of new tariff schedules by the United States in early 2025 has significantly impacted the cost structure and sourcing strategies related to superdisintegrant raw materials. Import duties now target several specialty starch derivatives and high-performance polymers, elevating landed costs and squeezing margins for formulators reliant on overseas suppliers. In response, many manufacturers are diversifying procurement channels, forging partnerships with domestic granule and powder producers to mitigate exposure to duty escalations. Meanwhile, vertically integrated players are exploring backward integration opportunities, investing in regional extraction facilities to secure feedstock and reduce import dependency. The tariff-driven price adjustments have also reshaped negotiation dynamics with distribution and research laboratory customers, forcing a recalibration of service agreements and inventory management practices. As downstream stakeholders confront tighter cost controls, the emphasis on high-efficiency superdisintegrants that perform optimally at minimal loadings has intensified, offering a pathway to offset increased raw material expenses. Ultimately, the cumulative impact of these measures underscores the need for dynamic supply chain resilience and agile sourcing frameworks in an era of evolving trade policies.

Key Insights Across Market Segmentations

Detailed segmentation analysis reveals distinct performance drivers and strategic opportunities across multiple dimensions. Examining product types highlights a bifurcation between natural superdisintegrants-represented by alginates, gums and starch-and synthetic superdisintegrants characterized by crospovidone, crosscarmellose sodium and sodium starch glycolate, each offering unique disintegration kinetics and compatibility profiles. Formulation-based segmentation uncovers varied adoption trends in capsules, orally disintegrating tablets and traditional tablets; the gelatin and hydroxypropyl methylcellulose variants for capsules, the freeze-dried and molded formats for orally disintegrating tablets, and the immediate release and sustained release options for tablets emphasize targeted application strategies. Therapeutic area insights span cardiovascular, gastrointestinal, infectious and neurological disorders, with tailored excipient selections optimizing drug release according to disease-specific absorption windows. End users encompass academic institutes, pharmaceutical companies and research laboratories, each prioritizing different performance criteria-academic research focusing on novel mechanisms, pharmaceutical firms demanding consistency at scale, and research labs emphasizing screening versatility. Distribution channels range from offline outlets such as pharmacy stores and retail stores to digital marketplaces online, while final dosage form distinctions include granules, liquid form and powder, underscoring the importance of physical characteristics in downstream processing and product stability.

Regional Dynamics Driving Superdisintegrants Adoption

Regional dynamics exert a profound influence on market trajectories, with each geography displaying unique adoption patterns and regulatory considerations. In the Americas, established pharmaceutical hubs leverage mature distribution networks and robust academic collaboration to accelerate product launches, while domestic tariff policies continue to shape raw material sourcing strategies. Across Europe, Middle East & Africa, stringent excipient quality standards and the drive toward digital track-and-trace systems foster a climate of regulatory compliance and supply chain visibility, prompting manufacturers to invest in regional processing capabilities. In the Asia-Pacific region, burgeoning research and manufacturing ecosystems in emerging economies are catalyzing rapid uptake of both natural and synthetic superdisintegrants, supported by favorable government incentives and expanding contract development and manufacturing organizations. These regional nuances inform tailored market entry strategies and partnership models, guiding stakeholders toward optimized production footprints, compliance frameworks and distribution alliances that align with local regulatory environments and customer expectations.

Strategic Profiles of Leading Superdisintegrant Suppliers

Competitive intensity within the superdisintegrants sphere is underscored by a diverse array of global and regional suppliers, each vying to differentiate through performance, sustainability credentials and scale. Leading specialty chemical players such as Anshul Life Sciences, Asahi Kasei Corporation and BASF SE leverage extensive R&D pipelines to introduce next-generation polymers and natural derivatives. Companies like Ashland Global Specialty Chemicals Inc., Avantor Performance Materials, LLC and DFE Pharma GmbH & Co KG emphasize strong distribution networks and regulatory support, facilitating rapid market entry for novel excipient grades. DowDuPont Inc., FMC Corporation and Roquette Frères S.A. capitalize on vertically integrated operations to secure raw material supply and ensure consistent quality standards. Regional specialists including Gangwal Chemicals Pvt. Ltd., Huber Corporation and Sigachi Industries Pvt Ltd. offer tailored solutions that address local manufacturing and regulatory needs, while Nippon Soda Co., Ltd., NITIKA PHARMACEUTICAL SPECIALITIES PVT. LTD. and JRS PHARMA GmbH + Co. KG focus on niche applications and specialty formats. This competitive landscape demands continuous innovation, strategic alliances and value-added services to sustain leadership positions.

Strategic Recommendations for Industry Stakeholders

Industry leaders must proactively embrace several strategic initiatives to navigate evolving market conditions. First, enhancing supply chain resilience through multi-sourcing agreements and localized production facilities will mitigate exposure to tariff fluctuations and trade disruptions. Second, investing in advanced excipient characterization technologies-such as real-time particle size analyzers and dissolution simulators-will accelerate formulation development and reduce time to market. Third, collaborating with regulatory bodies to co-develop standardized testing methodologies will streamline approval pathways and bolster quality assurance. Fourth, fostering partnerships with contract development and manufacturing organizations that specialize in innovative dosage forms can unlock new market segments, particularly in personalized medicine and on-demand manufacturing. Finally, integrating sustainability metrics into product lifecycles-from raw material extraction through end-of-life disposal-will appeal to environmentally conscious stakeholders and preempt regulatory mandates, while driving cost efficiencies through waste reduction and resource optimization.

Conclusion: Charting the Path Forward

In summary, the superdisintegrants market stands at a pivotal juncture, driven by regulatory evolutions, trade policy realignments and rapid technological advancements. Stakeholders must cultivate a dual focus on innovation and operational agility, balancing the introduction of next-generation materials with robust supply chain strategies that address emerging tariff pressures. Detailed segmentation insights underscore the importance of tailoring product portfolios to specific therapeutic applications, dosage formats and end-user requirements, while regional nuances necessitate localized compliance frameworks and distribution partnerships. Competitive positioning will hinge on an organization’s ability to deliver consistent quality, sustainable sourcing and value-added services, supported by rigorous excipient characterization and collaborative regulatory engagement. By adopting a proactive, integrated approach that marries scientific excellence with strategic foresight, industry participants can capitalize on growth opportunities, mitigate risks and chart a clear path toward long-term resilience and market leadership.

Market Segmentation & Coverage

This research report categorizes the Superdisintegrants Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Natural Superdisintegrants
    • Alginates
    • Gums
    • Starch
  • Synthetic Superdisintegrants
    • Crospovidone
    • Crosscarmellose Sodium
    • Sodium Starch Glycolate
  • Capsules
    • Gelatin
    • Hydroxypropyl Methylcellulose
  • Orally Disintegrating Tablets (ODT)
    • Freeze-Dried
    • Molded
  • Tablets
    • Immediate Release
    • Sustained Release
  • Cardiovascular Disorders
  • Gastrointestinal Disorders
  • Infectious Diseases
  • Neurological Disorders
  • Academic Institutes
  • Pharmaceutical Companies
  • Research Laboratories
  • Offline
    • Pharmacy Stores
    • Retail Stores
  • Online
  • Granules
  • Liquid Form
  • Powder

This research report categorizes the Superdisintegrants Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Superdisintegrants Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Anshul Life Sciences
  • Asahi Kasei Corporation
  • Ashland Global Specialty Chemicals Inc.
  • Avantor Performance Materials, LLC
  • BASF SE
  • DFE Pharma GmbH & Co KG
  • DowDuPont Inc.
  • FMC Corporation
  • Gangwal Chemicals Pvt. Ltd.
  • Huber Corporation
  • JRS PHARMA GmbH + Co. KG
  • Nippon Soda Co., Ltd.
  • NITIKA PHARMACEUTICAL SPECIALITIES PVT. LTD.
  • Roquette Frères S.A.
  • Sigachi Industries Pvt Ltd.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Superdisintegrants Market, by Product Type
8.1. Introduction
8.2. Natural Superdisintegrants
8.2.1. Alginates
8.2.2. Gums
8.2.3. Starch
8.3. Synthetic Superdisintegrants
8.3.1. Crospovidone
8.3.2. Crosscarmellose Sodium
8.3.3. Sodium Starch Glycolate
9. Superdisintegrants Market, by Formulation Type
9.1. Introduction
9.2. Capsules
9.2.1. Gelatin
9.2.2. Hydroxypropyl Methylcellulose
9.3. Orally Disintegrating Tablets (ODT)
9.3.1. Freeze-Dried
9.3.2. Molded
9.4. Tablets
9.4.1. Immediate Release
9.4.2. Sustained Release
10. Superdisintegrants Market, by Therapeutic Area
10.1. Introduction
10.2. Cardiovascular Disorders
10.3. Gastrointestinal Disorders
10.4. Infectious Diseases
10.5. Neurological Disorders
11. Superdisintegrants Market, by End User
11.1. Introduction
11.2. Academic Institutes
11.3. Pharmaceutical Companies
11.4. Research Laboratories
12. Superdisintegrants Market, by Distribution Channel
12.1. Introduction
12.2. Offline
12.2.1. Pharmacy Stores
12.2.2. Retail Stores
12.3. Online
13. Superdisintegrants Market, by Form
13.1. Introduction
13.2. Granules
13.3. Liquid Form
13.4. Powder
14. Americas Superdisintegrants Market
14.1. Introduction
14.2. Argentina
14.3. Brazil
14.4. Canada
14.5. Mexico
14.6. United States
15. Asia-Pacific Superdisintegrants Market
15.1. Introduction
15.2. Australia
15.3. China
15.4. India
15.5. Indonesia
15.6. Japan
15.7. Malaysia
15.8. Philippines
15.9. Singapore
15.10. South Korea
15.11. Taiwan
15.12. Thailand
15.13. Vietnam
16. Europe, Middle East & Africa Superdisintegrants Market
16.1. Introduction
16.2. Denmark
16.3. Egypt
16.4. Finland
16.5. France
16.6. Germany
16.7. Israel
16.8. Italy
16.9. Netherlands
16.10. Nigeria
16.11. Norway
16.12. Poland
16.13. Qatar
16.14. Russia
16.15. Saudi Arabia
16.16. South Africa
16.17. Spain
16.18. Sweden
16.19. Switzerland
16.20. Turkey
16.21. United Arab Emirates
16.22. United Kingdom
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Anshul Life Sciences
17.3.2. Asahi Kasei Corporation
17.3.3. Ashland Global Specialty Chemicals Inc.
17.3.4. Avantor Performance Materials, LLC
17.3.5. BASF SE
17.3.6. DFE Pharma GmbH & Co KG
17.3.7. DowDuPont Inc.
17.3.8. FMC Corporation
17.3.9. Gangwal Chemicals Pvt. Ltd.
17.3.10. Huber Corporation
17.3.11. JRS PHARMA GmbH + Co. KG
17.3.12. Nippon Soda Co., Ltd.
17.3.13. NITIKA PHARMACEUTICAL SPECIALITIES PVT. LTD.
17.3.14. Roquette Frères S.A.
17.3.15. Sigachi Industries Pvt Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. SUPERDISINTEGRANTS MARKET MULTI-CURRENCY
FIGURE 2. SUPERDISINTEGRANTS MARKET MULTI-LANGUAGE
FIGURE 3. SUPERDISINTEGRANTS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 18. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. SUPERDISINTEGRANTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. SUPERDISINTEGRANTS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SUPERDISINTEGRANTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY ALGINATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY GUMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY STARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY CROSPOVIDONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY CROSSCARMELLOSE SODIUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY SODIUM STARCH GLYCOLATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY GELATIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY HYDROXYPROPYL METHYLCELLULOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY ORALLY DISINTEGRATING TABLETS (ODT), BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY FREEZE-DRIED, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY MOLDED, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY ORALLY DISINTEGRATING TABLETS (ODT), 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY SUSTAINED RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY PHARMACY STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY RETAIL STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY GRANULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY LIQUID FORM, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY ORALLY DISINTEGRATING TABLETS (ODT), 2018-2030 (USD MILLION)
TABLE 55. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA SUPERDISINTEGRANTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA SUPERDISINTEGRANTS MARKET SIZE, BY ORALLY DISINTEGRATING TABLETS (ODT), 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA SUPERDISINTEGRANTS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA SUPERDISINTEGRANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA SUPERDISINTEGRANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA SUPERDISINTEGRANTS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA SUPERDISINTEGRANTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL SUPERDISINTEGRANTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL SUPERDISINTEGRANTS MARKET SIZE, BY ORALLY DISINTEGRATING TABLETS (ODT), 2018-2030 (USD MILLION)
TABLE 80. BRAZIL SUPERDISINTEGRANTS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL SUPERDISINTEGRANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL SUPERDISINTEGRANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL SUPERDISINTEGRANTS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL SUPERDISINTEGRANTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 86. CANADA SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 87. CANADA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 88. CANADA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 89. CANADA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 90. CANADA SUPERDISINTEGRANTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 91. CANADA SUPERDISINTEGRANTS MARKET SIZE, BY ORALLY DISINTEGRATING TABLETS (ODT), 2018-2030 (USD MILLION)
TABLE 92. CANADA SUPERDISINTEGRANTS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 93. CANADA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 94. CANADA SUPERDISINTEGRANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. CANADA SUPERDISINTEGRANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. CANADA SUPERDISINTEGRANTS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 97. CANADA SUPERDISINTEGRANTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 98. MEXICO SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 99. MEXICO SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 100. MEXICO SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 101. MEXICO SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 102. MEXICO SUPERDISINTEGRANTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 103. MEXICO SUPERDISINTEGRANTS MARKET SIZE, BY ORALLY DISINTEGRATING TABLETS (ODT), 2018-2030 (USD MILLION)
TABLE 104. MEXICO SUPERDISINTEGRANTS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 105. MEXICO SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 106. MEXICO SUPERDISINTEGRANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. MEXICO SUPERDISINTEGRANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. MEXICO SUPERDISINTEGRANTS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 109. MEXICO SUPERDISINTEGRANTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY ORALLY DISINTEGRATING TABLETS (ODT), 2018-2030 (USD MILLION)
TABLE 116. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 117. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 118. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 121. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 122. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 123. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 124. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 125. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 126. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 127. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 128. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY ORALLY DISINTEGRATING TABLETS (ODT), 2018-2030 (USD MILLION)
TABLE 129. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 130. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 131. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 133. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 134. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 135. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 136. AUSTRALIA SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 137. AUSTRALIA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 138. AUSTRALIA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 139. AUSTRALIA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 140. AUSTRALIA SUPERDISINTEGRANTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 141. AUSTRALIA SUPERDISINTEGRANTS MARKET SIZE, BY ORALLY DISINTEGRATING TABLETS (ODT), 2018-2030 (USD MILLION)
TABLE 142. AUSTRALIA SUPERDISINTEGRANTS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 143. AUSTRALIA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 144. AUSTRALIA SUPERDISINTEGRANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. AUSTRALIA SUPERDISINTEGRANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. AUSTRALIA SUPERDISINTEGRANTS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 147. AUSTRALIA SUPERDISINTEGRANTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 148. CHINA SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. CHINA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 150. CHINA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 151. CHINA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 152. CHINA SUPERDISINTEGRANTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 153. CHINA SUPERDISINTEGRANTS MARKET SIZE, BY ORALLY DISINTEGRATING TABLETS (ODT), 2018-2030 (USD MILLION)
TABLE 154. CHINA SUPERDISINTEGRANTS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 155. CHINA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 156. CHINA SUPERDISINTEGRANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. CHINA SUPERDISINTEGRANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 158. CHINA SUPERDISINTEGRANTS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 159. CHINA SUPERDISINTEGRANTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 160. INDIA SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 161. INDIA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 162. INDIA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 163. INDIA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 164. INDIA SUPERDISINTEGRANTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 165. INDIA SUPERDISINTEGRANTS MARKET SIZE, BY ORALLY DISINTEGRATING TABLETS (ODT), 2018-2030 (USD MILLION)
TABLE 166. INDIA SUPERDISINTEGRANTS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 167. INDIA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 168. INDIA SUPERDISINTEGRANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. INDIA SUPERDISINTEGRANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 170. INDIA SUPERDISINTEGRANTS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 171. INDIA SUPERDISINTEGRANTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 172. INDONESIA SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 173. INDONESIA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 174. INDONESIA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 175. INDONESIA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 176. INDONESIA SUPERDISINTEGRANTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 177. INDONESIA SUPERDISINTEGRANTS MARKET SIZE, BY ORALLY DISINTEGRATING TABLETS (ODT), 2018-2030 (USD MILLION)
TABLE 178. INDONESIA SUPERDISINTEGRANTS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 179. INDONESIA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 180. INDONESIA SUPERDISINTEGRANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. INDONESIA SUPERDISINTEGRANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. INDONESIA SUPERDISINTEGRANTS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 183. INDONESIA SUPERDISINTEGRANTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 184. JAPAN SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 185. JAPAN SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 186. JAPAN SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 187. JAPAN SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 188. JAPAN SUPERDISINTEGRANTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 189. JAPAN SUPERDISINTEGRANTS MARKET SIZE, BY ORALLY DISINTEGRATING TABLETS (ODT), 2018-2030 (USD MILLION)
TABLE 190. JAPAN SUPERDISINTEGRANTS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 191. JAPAN SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 192. JAPAN SUPERDISINTEGRANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. JAPAN SUPERDISINTEGRANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. JAPAN SUPERDISINTEGRANTS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 195. JAPAN SUPERDISINTEGRANTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 196. MALAYSIA SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 197. MALAYSIA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 198. MALAYSIA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 199. MALAYSIA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 200. MALAYSIA SUPERDISINTEGRANTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 201. MALAYSIA SUPERDISINTEGRANTS MARKET SIZE, BY ORALLY DISINTEGRATING TABLETS (ODT), 2018-2030 (USD MILLION)
TABLE 202. MALAYSIA SUPERDISINTEGRANTS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 203. MALAYSIA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 204. MALAYSIA SUPERDISINTEGRANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 205. MALAYSIA SUPERDISINTEGRANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 206. MALAYSIA SUPERDISINTEGRANTS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 207. MALAYSIA SUPERDISINTEGRANTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 208. PHILIPPINES SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 209. PHILIPPINES SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 210. PHILIPPINES SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 211. PHILIPPINES SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 212. PHILIPPINES SUPERDISINTEGRANTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 213. PHILIPPINES SUPERDISINTEGRANTS MARKET SIZE, BY ORALLY DISINTEGRATING TABLETS (ODT), 2018-2030 (USD MILLION)
TABLE 214. PHILIPPINES SUPERDISINTEGRANTS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 215. PHILIPPINES SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 216. PHILIPPINES SUPERDISINTEGRANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. PHILIPPINES SUPERDISINTEGRANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 218. PHILIPPINES SUPERDISINTEGRANTS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 219. PHILIPPINES SUPERDISINTEGRANTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 220. SINGAPORE SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 221. SINGAPORE SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 222. SINGAPORE SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 223. SINGAPORE SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 224. SINGAPORE SUPERDISINTEGRANTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 225. SINGAPORE SUPERDISINTEGRANTS MARKET SIZE, BY ORALLY DISINTEGRATING TABLETS (ODT), 2018-2030 (USD MILLION)
TABLE 226. SINGAPORE SUPERDISINTEGRANTS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 227. SINGAPORE SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 228. SINGAPORE SUPERDISINTEGRANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. SINGAPORE SUPERDISINTEGRANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 230. SINGAPORE SUPERDISINTEGRANTS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 231. SINGAPORE SUPERDISINTEGRANTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 232. SOUTH KOREA SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 233. SOUTH KOREA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 234. SOUTH KOREA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 235. SOUTH KOREA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 236. SOUTH KOREA SUPERDISINTEGRANTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 237. SOUTH KOREA SUPERDISINTEGRANTS MARKET SIZE, BY ORALLY DISINTEGRATING TABLETS (ODT), 2018-2030 (USD MILLION)
TABLE 238. SOUTH KOREA SUPERDISINTEGRANTS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 239. SOUTH KOREA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 240. SOUTH KOREA SUPERDISINTEGRANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 241. SOUTH KOREA SUPERDISINTEGRANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 242. SOUTH KOREA SUPERDISINTEGRANTS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 243. SOUTH KOREA SUPERDISINTEGRANTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 244. TAIWAN SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 245. TAIWAN SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 246. TAIWAN SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 247. TAIWAN SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 248. TAIWAN SUPERDISINTEGRANTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 249. TAIWAN SUPERDISINTEGRANTS MARKET SIZE, BY ORALLY DISINTEGRATING TABLETS (ODT), 2018-2030 (USD MILLION)
TABLE 250. TAIWAN SUPERDISINTEGRANTS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 251. TAIWAN SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 252. TAIWAN SUPERDISINTEGRANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. TAIWAN SUPERDISINTEGRANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 254. TAIWAN SUPERDISINTEGRANTS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 255. TAIWAN SUPERDISINTEGRANTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 256. THAILAND SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 257. THAILAND SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 258. THAILAND SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 259. THAILAND SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 260. THAILAND SUPERDISINTEGRANTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 261. THAILAND SUPERDISINTEGRANTS MARKET SIZE, BY ORALLY DISINTEGRATING TABLETS (ODT), 2018-2030 (USD MILLION)
TABLE 262. THAILAND SUPERDISINTEGRANTS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 263. THAILAND SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 264. THAILAND SUPERDISINTEGRANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 265. THAILAND SUPERDISINTEGRANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 266. THAILAND SUPERDISINTEGRANTS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 267. THAILAND SUPERDISINTEGRANTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 268. VIETNAM SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 269. VIETNAM SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 270. VIETNAM SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 271. VIETNAM SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 272. VIETNAM SUPERDISINTEGRANTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 273. VIETNAM SUPERDISINTEGRANTS MARKET SIZE, BY ORALLY DISINTEGRATING TABLETS (ODT), 2018-2030 (USD MILLION)
TABLE 274. VIETNAM SUPERDISINTEGRANTS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 275. VIETNAM SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 276. VIETNAM SUPERDISINTEGRANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 277. VIETNAM SUPERDISINTEGRANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 278. VIETNAM SUPERDISINTEGRANTS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 279. VIETNAM SUPERDISINTEGRANTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY ORALLY DISINTEGRATING TABLETS (ODT), 2018-2030 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 293. DENMARK SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 294. DENMARK SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 295. DENMARK SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 296. DENMARK SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 297. DENMARK SUPERDISINTEGRANTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 298. DENMARK SUPERDISINTEGRANTS MARKET SIZE, BY ORALLY DISINTEGRATING TABLETS (ODT), 2018-2030 (USD MILLION)
TABLE 299. DENMARK SUPERDISINTEGRANTS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 300. DENMARK SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 301. DENMARK SUPERDISINTEGRANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 302. DENMARK SUPERDISINTEGRANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 303. DENMARK SUPERDISINTEGRANTS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 304. DENMARK SUPERDISINTEGRANTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 305. EGYPT SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 306. EGYPT SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 307. EGYPT SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 308. EGYPT SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 309. EGYPT SUPERDISINTEGRANTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 310. EGYPT SUPERDISINTEGRANTS MARKET SIZE, BY ORALLY DISINTEGRATING TABLETS (ODT), 2018-2030 (USD MILLION)
TABLE 311. EGYPT SUPERDISINTEGRANTS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 312. EGYPT SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 313. EGYPT SUPERDISINTEGRANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 314. EGYPT SUPERDISINTEGRANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 315. EGYPT SUPERDISINTEGRANTS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 316. EGYPT SUPERDISINTEGRANTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 317. FINLAND SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 318. FINLAND SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 319. FINLAND SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 320. FINLAND SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 321. FINLAND SUPERDISINTEGRANTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 322. FINLAND SUPERDISINTEGRANTS MARKET SIZE, BY ORALLY DISINTEGRATING TABLETS (ODT), 2018-2030 (USD MILLION)
TABLE 323. FINLAND SUPERDISINTEGRANTS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 324. FINLAND SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 325. FINLAND SUPERDISINTEGRANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 326. FINLAND SUPERDISINTEGRANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 327. FINLAND SUPERDISINTEGRANTS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 328. FINLAND SUPERDISINTEGRANTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 329. FRANCE SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 330. FRANCE SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 331. FRANCE SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
TABLE 332. FRANCE SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 333. FRANCE SUPERDISINTEGRANTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 334. FRANCE SUPERDISINTEGRANTS MARKET SIZE, BY ORALLY DISINTEGRATING TABLETS (ODT), 2018-2030 (USD MILLION)
TABLE 335. FRANCE SUPERDISINTEGRANTS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 336. FRANCE SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 337. FRANCE SUPERDISINTEGRANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
T

Companies Mentioned

  • Anshul Life Sciences
  • Asahi Kasei Corporation
  • Ashland Global Specialty Chemicals Inc.
  • Avantor Performance Materials, LLC
  • BASF SE
  • DFE Pharma GmbH & Co KG
  • DowDuPont Inc.
  • FMC Corporation
  • Gangwal Chemicals Pvt. Ltd.
  • Huber Corporation
  • JRS PHARMA GmbH + Co. KG
  • Nippon Soda Co., Ltd.
  • NITIKA PHARMACEUTICAL SPECIALITIES PVT. LTD.
  • Roquette Frères S.A.
  • Sigachi Industries Pvt Ltd.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Superdisintegrants Market Report by Product, Type, Dosage Form, Therapeutic Areas, and Region 2024-2032 - Product Image

Superdisintegrants Market Report by Product, Type, Dosage Form, Therapeutic Areas, and Region 2024-2032

  • Report
  • 148 Pages
  • Global
From
Superdisintegrants - Global Strategic Business Report - Product Image

Superdisintegrants - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Superdisintegrants Market Size, Share & Trends Analysis Report By Product (Croscarmellose Sodium, Crospovidone), By Form (Tablets and Capsules, Mouth-dissolving Films), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Superdisintegrants Market Size, Share & Trends Analysis Report By Product (Croscarmellose Sodium, Crospovidone), By Form (Tablets and Capsules, Mouth-dissolving Films), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Superdisintegrant Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Superdisintegrant Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 85 Pages
  • Global
From
2024 Global Forecast for Superdisintegrants Market (2025-2030 Outlook)-High Tech & Emerging Markets Report - Product Image

2024 Global Forecast for Superdisintegrants Market (2025-2030 Outlook)-High Tech & Emerging Markets Report

  • Report
  • 132 Pages
  • Global
From

About the Superdisintegrant Market

Superdisintegrants are pharmaceutical intermediates used to facilitate the disintegration of tablets and capsules in the gastrointestinal tract. They are typically composed of polymers, starches, or cellulose derivatives, and are used to increase the rate of dissolution of the active pharmaceutical ingredient. Superdisintegrants are used in a variety of pharmaceutical formulations, including tablets, capsules, and granules. Superdisintegrants are used to improve the bioavailability of drugs, reduce the time to onset of action, and improve patient compliance. They are also used to reduce the size of tablets, improve the flowability of powders, and reduce the cost of production. Some of the companies in the Superdisintegrant market include BASF, Colorcon, Dow, Evonik, JRS Pharma, Roquette, and Wacker Chemie. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.